Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...

HIMS expands its tech-driven care with new diagnostics, hormonal treatments, and a Canada launch via Livewell.

The transaction closure is anticipated in early 2026, contingent on regulatory approvals and other customary conditions.

Delving into the details, we found 53% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $373,316, and 7 were calls, valued ...

Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact. Read why HIMS stock is a ...

Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Shares of Hims & Hers are trending Thursday morning. The San Francisco-based telehealth company announced an international ...

Hims & Hers Health (HIMS) has entered into an agreement to acquire YourBio Health, a Boston-based maker of capillary whole ...

Hims & Hers Health ($HIMS) is strengthening its position in the UK with the launch of weight-loss programs. This launch will ...

The move into the UK weight-loss category has been facilitated by the acquisition earlier this year of Zava, a London-based ...

Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers.

Hims & Hers Health recently reported strong year-over-year revenue growth but a steep earnings per share decline, shrinking margins, and higher operating expenses, while also authorizing a US$250 ...